ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Recombinant Anti-SLC44A4 Antibody [ASG-5ME] - Low endotoxin, Azide free (A324247)

Recombinant human monoclonal [ASG-5ME] antibody to SLC44A4 for ELISA, FACS, Functional Assay and In Vivo.

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 12-18 business days.
Name
Anti-SLC44A4 Antibody [ASG-5ME] - Low endotoxin, Azide free
Description
Recombinant human monoclonal [ASG-5ME] antibody to SLC44A4.
Applications
ELISA, FACS, Functional Assay, In Vivo
Reactivity
Human, Mouse
Host
Human
Clonality
Monoclonal
Clone ID
ASG-5ME
Isotype
IgG2SA - Human IgG2 with S387A mutation
Light Chains
kappa
Conjugate

Unconjugated

Purification
Protein A affinity chromatography.
Concentration
Reconstitution dependent.
Molecular Weight
This antibody has a predicted MW of 155.4 kDa.
Purity
> 95% (by SDS-PAGE and SEC-HPLC).
Product Form
Lyophilized
Reconstitution
Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!
Formulation
Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.
Storage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
Synonyms
C6orf29, Choline transporter-like protein 4, CTL4, hTPPT1, NG22, Solute carrier family 44 member 4, Thiamine pyrophosphate transporter 1, TPPT1
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Recombinant Anti-SLC44A4 Antibody [ASG-5ME] - Low endotoxin, Azide free (A324247)? Please let us know so that we can list the citation on this page.

Alternative products to Anti-SLC44A4 Antibody [ASG-5ME] - Low endotoxin, Azide free (A324247)

Proteins predicted to interact with SLC44A4

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
92.7% Relevancy Score
82.6% Relevancy Score
58.5% Relevancy Score
55.1% Relevancy Score
52.1% Relevancy Score
48.2% Relevancy Score
43.5% Relevancy Score
42.7% Relevancy Score
40.9% Relevancy Score